OKYO Pharma Limited - ADR

The momentum for this stock is not very good. OKYO Pharma Limited - ADR is not very popular among insiders. Tradey thinks it is not wise to invest in OKYO Pharma Limited - ADR.
Log in to see more information.

News

Okyo Pharma announces acquisition of shares by chairman
Okyo Pharma announces acquisition of shares by chairman

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

OKYO Pharma Announces Chairman Acquires Shares
OKYO Pharma Announces Chairman Acquires Shares

Globe Newswire LONDON and NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...\n more…

OKYO Pharma Chairman Boosts Stake, Advances Trials
OKYO Pharma Chairman Boosts Stake, Advances Trials

TipRanks Financial Blog OKYO Pharma Limited Sponsored ADR (OKYO) has released an update. OKYO Pharma Limited announced the purchase of 80,000 ordinary shares by Panetta Partners Limited, a...\n more…

Okyo Pharma announces acquisition of shares by chairman
Okyo Pharma announces acquisition of shares by chairman

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

OKYO Pharma Announces Chairman Acquires Shares
OKYO Pharma Announces Chairman Acquires Shares

Globe Newswire LONDON and NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...\n more…

OKYO Pharma (NASDAQ:OKYO) & Moderna (NASDAQ:MRNA) Financial Analysis
OKYO Pharma (NASDAQ:OKYO) & Moderna (NASDAQ:MRNA) Financial Analysis

Ticker Report OKYO Pharma (NASDAQ:OKYO - Get Free Report) and Moderna (NASDAQ:MRNA - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the...\n more…